Traws Pharma Inc.

NASDAQ: TRAW · Real-Time Price · USD
1.52
-0.10 (-6.17%)
At close: Aug 15, 2025, 10:01 AM

Traws Pharma Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
226K 226K 226K 226K
Cost of Revenue
12K 16K 14K 14K
Gross Profit
214K 210K 212K 212K
Operating Income
-49.35M -20.3M -19.63M -16.5M
Interest Income
n/a n/a n/a n/a
Pretax Income
-166.52M -18.95M -18.96M -16.16M
Net Income
-54.67M -18.95M -18.96M -16.16M
Selling & General & Admin
12.29M 9.09M 8.45M 9.43M
Research & Development
12.84M 11.41M 11.39M 7.28M
Other Expenses
-24.44M n/a n/a n/a
Operating Expenses
49.56M 20.51M 19.84M 16.71M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
49.57M 20.52M 19.85M 16.72M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
1.55M 839.55K 836.33K 673.29K
Shares Outstanding (Diluted)
1.55M 839.55K 836.33K 673.29K
EPS (Basic)
-35.21 -22.57 -22.68 -24.01
EPS (Diluted)
-35.21 -22.57 -22.68 -24.01
EBITDA
-166.51M -18.93M -18.95M -16.15M
EBIT
-166.52M -18.95M -18.96M -16.16M
Depreciation & Amortization
12K 16K 14K 14K